"Ascension Via Christi Hospital St. Francis in Wichita, Kansas, is a full-service hospital with 24/7 emergency care. We deliver advanced surgical care for serious and life-threatening injuries and illnesses. Ascension Via Christi is a destination for primary care and specialty care - including heart care and a Comprehensive Stroke Center, Regional Burn Center, Cancer Center with CyberKnife technology, digestive health, Osteoporosis Detection Center, Orthopedic Joint Replacement Center, epilepsy seizure care, and wound healing. Our pediatric ChildLife Center includes a PICU and pediatric therapies. We offer extensive diagnostic imaging, lab tests, cardiopulmonary rehab, respiratory care and physical therapy, on one campus."

During the past decade, Via Christi Regional Medical Center - St. Francis Campus conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Via Christi Regional Medical Center - St. Francis Campus" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Children's Oncology Group" with 3 trials sponsored, "American Burn Association" with 1 trials sponsored, "Foldax, Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Via Christi Regional Medical Center - St. Francis Campus" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Children's Cancer Group" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Via Christi Regional Medical Center - St. Francis Campus" are "Coronary Artery Disease" (4 trials), "Coronary Stenosis" (2 trials), "Anemia" (1 trials), "Atherosclerosis" (1 trials) and "Bleeding Disorder" (1 trials). Many other conditions were trialed in "Via Christi Regional Medical Center - St. Francis Campus" in a lesser frequency.

Most popular intervention types in "Via Christi Regional Medical Center - St. Francis Campus" are "Device" (6 trials), "Drug" (6 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "vincristine sulfate" (4 trials), "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "doxorubicin hydrochloride" (2 trials) and "etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Via Christi Regional Medical Center - St. Francis Campus" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Via Christi Regional Medical Center - St. Francis Campus". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Via Christi Regional Medical Center - St. Francis Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Via Christi Regional Medical Center - St. Francis Campus, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".